Cindy Spittle

Cindy Spittle

Company: Molecular MD

Job title: Vice President, Scientific Affairs


Comprehensive Biomarker Strategies to Accelerate Adoptive Cell Therapy Development 9:00 am

Adoptive Cell Therapies (ACTs) harness the immune system to target cancer cells. Recent successes include two FDA-approved CAR-T immunotherapies The potential for ACTs appears limitless, from the exploration of new indications and combination therapies to novel cancer antigens Consequently, the complexity of immunotherapy clinical trials increases rapidly. Key challenges include regulatory and operational risks that…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.